University of Pittsburgh researchers have found a novel trigger of high-grade serous ovarian cancer (HGSOC). Discovery of high-risk progenitor cells located in the fallopian tube supportive tissue could lead to enhanced prevention and detection methods. HGSOC, the deadliest form of ovarian cancer, begins in the fallopian tubes and often progresses from precursor lesions called serous tubal intraepithelial carcinoma (STIC). The findings may provide a prevention or reversal scenario for ovarian cancer, and lend insight into better early detection strategies.
Compliancy Group Acquires Healthicity
Compliancy Group has acquired Healthicity in a deal that combines two healthcare compliance software companies and expands Compliancy Group’s platform to include healthcare compliance, workforce
